
Oral Health Service Provider
VCBeat has learned that, following its announcement in July of securing over RMB 1 billion in Series B financing, MEI WEI DENTAL GROUP (hereinafter referred to as “MEI WEI DENTAL”) has recently completed its Series B+ round of financing. Investors in this round include Ruihua Capital and Dice Investment, among others.
Founded in 2016, MEI WEI DENTAL GROUP is China’s first platform-level dental healthcare enterprise developed under the “DSO” model. It has pioneered new development models and business formats within China’s dental industry, and continues to empower outstanding domestic dental chain brands and experts through comprehensive support spanning strategic investment, standardization, medical technology enhancement, brand management, and digital transformation, thereby facilitating rapid and personalized growth.
It is worth noting that in the inaugural year of the 14th Five-Year Plan, investment in hard technology, frontier technologies, and digital transformation have become significant drivers for the development of the technology industry. In the field of dental healthcare, which is closely related to public health, technological iterations are advancing at a rapid pace, continuously promoting industrial upgrading and industry transformation. Companies possessing specialized frontier medical technologies, high-caliber talent resources, high-quality diagnostic and treatment services, and excellent operational performance have attracted considerable attention from capital markets, as evidenced by the frequent investor interest in MEI WEI DENTAL GROUP.
It is reported that, following the completion of this round of financing, the newly raised funds will continue to be allocated to brand empowerment and development, medical talent cultivation, and the advancement of digital and intelligent transformation in healthcare and operations.
In 2016, MEI WEI DENTAL GROUP was co-founded in Shanghai by Chairman Mr. Yu Rong, CEO Ms. Zhu Liya, and the team of founding partners. Despite achieving a significant breakthrough from one to nearly 200 dental institutions within just five years, Ms. Zhu Liya stated, “The core competitiveness of a dental healthcare chain lies not in the number of clinics, but in the genuine implementation and execution of a management model and philosophy.”
Currently, MEI WEI DENTAL GROUP owns 16 dental brands and boasts the largest and highest-quality team of business partners. Among the 35 cities it covers, approximately 70% have achieved a leading market position. This demonstrates that the “DSO” model, introduced by the founding team from abroad and innovatively adapted to China’s local conditions, can be effectively implemented in China.
Mr. Xu Xiaohui, Vice President of Investment at MEI WEI DENTAL GROUP, stated, “In the long run, chain expansion is an inevitable trend in the industry’s development, with market share increasingly concentrating among leading enterprises. MEI WEI DENTAL GROUP strives to achieve its new strategic objectives and industrial layout, aiming to become a trusted partner working hand in hand with all stakeholders.”
In the field of dental care, digitalization and intelligence have become inevitable trends. Whether it is the digital innovation in dental technologies and equipment or the intelligent upgrade of medical facility office systems, these advancements bring significant convenience to healthcare practitioners.
As one of the dental chain organizations with a highly advanced level of information management, MEI WEI DENTAL GROUP has made informatization construction its core development strategy since its inception. The Wei Xiaomei Medical Cloud Intelligent Management Platform is built around the concept of “patient + medical care.” It enhances clinic operational efficiency by optimizing standard operating procedures (SOPs) and customer relationship management (CRM), implementing an intelligent appointment system, formulating refined and personalized full-mouth treatment plans, tracking oral health issues, and managing long-term oral health. This platform significantly improves clinic operations, particularly by freeing dentists and managers from tedious administrative tasks, allowing them to devote more time and energy to patient care.
Zhu Liya stated that MEI WEI DENTAL GROUP will continue to embrace high technology with an open and pragmatic mindset, vigorously introducing cutting-edge technologies such as big data and AI-powered imaging, augmented reality (AR), the Internet of Things (IoT), and blockchain to enhance their integrated application in clinical practice. Meanwhile, the group will build comfortable, digital dental hospitals and establish a digital remote diagnosis and treatment center to enable the sharing of expert medical resources, further improve the operational efficiency of its affiliated clinics, and provide patients with high-quality, efficient, and comprehensive medical services.
“Rooted in Oral Care, Transcending Oral Care.” MEI WEI DENTAL GROUP is committed to building China’s leading private dental platform. Adhering to the core development strategy of “Healthcare + Technology + Partnership,” we continuously expand our corporate boundaries, create greater industry value, and drive the dental sector into the era of digital intelligence. By serving as a trusted partner for more industry institutions, we join hands to forge a sustainable and prosperous future.
About Ruihua Capital:
Ruihua Capital’s business scope encompasses investments in the publicly traded equity market, private equity, private placements, private (trust) funds, and financial derivatives. Its equity investments are strategically focused on key sectors such as big health, new energy, and semiconductors. Upholding the Ruihua values of “Integrity, Excellence, Win-Win Cooperation, Long-Term Vision, and Ethical Practice,” the firm provides comprehensive value-added services to enterprises, serving as their long-term strategic partner.
About Dice Investment:
Dice Investment is a wholly-owned investment platform under Hunan Valin Group, a large state-owned backbone enterprise in Hunan Province. Its business scope covers equity investment, private placements of listed company stocks, and financial leasing, with assets under management exceeding RMB 10 billion. Since its establishment, Dice Investment has actively laid out five major sectors: intelligent manufacturing, TMT, the steel industry chain, new materials, and biopharmaceuticals. In the secondary market of the biopharmaceutical sector, it has invested in projects such as Dian Diagnostics, Truking Technology, WuXi AppTec, Jiuzhou Pharmaceutical, and Tianyu Pharmaceuticals.